Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2020-03-27

Clinical Trial Update: Dosing Intervals of Opioid Medication for Chronic Pain [Phase 4]

View source ↗

Summary

Phase 4 trial on dosing intervals of an opioid for chronic pain was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Health Network, Toronto | Conditions: Chronic Pain | Phase 4 | Status: WITHDRAWN